Number of Shares
500,000.00
Current Holdings Value*
$40.55 Mil
% of Portfolio
4%
Total Estimate Gain
$322,554.50
% of Total Estimate Gain
9.58%

Affinity Asset Advisors, LLC's SPDR Biotech ETF Holding Summary

As of 2025-03-31, Affinity Asset Advisors, LLC held 500,000.00 shares of SPDR Biotech ETF(XBI), totaling $40.55 Mil. This investment constitutes 4% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 0.79% of the outstanding SPDR Biotech ETF(XBI) stock.

The initial trade took place in 2024Q2. And since then Affinity Asset Advisors, LLC has made 1 purchases of XBI, at an average price of $89.66, for a total of 37,550.00 shares. In addition, there have been 1 sales at an average price of $98.25 for 37,550.00 shares. Based on historical transaction data and XBI's current price of $84.88, Affinity Asset Advisors, LLC's estimated gain on his XBI holdings is $322,554.50, reflecting a 9.58% gain to date.

Affinity Asset Advisors, LLC XBI ($84.88) Holding Chart

Affinity Asset Advisors, LLC XBI ($84.88) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1